Synapse Open Synapse
Biology

Alamar, Nightingale Health Team up on UK Biobank Neurodegeneration Protein Study

GEN · · 2 min read

Nightingale Health will run the measurements in its labs using Alamar’s NULISA platform to quantify hundreds of blood proteins in 80,000 UK Biobank samples, seeking early molecular signs of neurodegeneration.

Latest from GEN